Literature DB >> 3584852

Pulmonary function in thyroid carcinoma metastatic to the lung.

L B Aldrich, J C Sisson, C M Grum.   

Abstract

Pulmonary testing was carried out in 12 of 35 consecutive cases of differentiated thyroid carcinoma metastatic to the lung, which were identified in a retrospective analysis covering the 22-yr period from 1962-1984. In 7 of the 12 patients, pulmonary function tests showed abnormalities. Impaired pulmonary function was associated with a poor prognosis. Four of the twelve patients died; each had impaired pulmonary function and their ages (12-65 yr) were similar to those still living (13-65 yr). Specific types of functional abnormalities were not associated with pulmonary metastases, and underlying pulmonary disease contributed to the findings in some patients. Four patterns were defined on chest radiographs: macronodular, micronodular, miliary, and normal, but these patterns did not correlate with outcome. Scintiscan patterns varied from normal to diffuse concentration of 131I. Generally, following therapy with radioiodine, fewer abnormalities on chest x-ray and less uptake of 131I in the lungs was noted. However, therapy with radioiodine did not improve pulmonary function. Pulmonary function testing appears to be a better predictor of outcome in patients with thyroid carcinoma metastatic to lung than chest x-ray appearance or scintigraphic scanning.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584852     DOI: 10.1007/BF03347168

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Treatment of thyroid carcinoma with I-131. Results at fourteen years.

Authors:  T P HAYNIE; M M NOFAL; W H BEIERWALTES
Journal:  JAMA       Date:  1963-02-02       Impact factor: 56.272

2.  Analysis of radioiodine therapy of metastatic tumors of the thyroid gland in man.

Authors:  S H WOLLMAN
Journal:  J Natl Cancer Inst       Date:  1953-02       Impact factor: 13.506

3.  [Roentgenological characteristic of pulmonary metastases in thyroid cancer in respect of its biological behaviour (author's transl)].

Authors:  J Nĕmec; V Zamrazil; D Pohunková; S Röhling; F Holík; V Zeman
Journal:  Rofo       Date:  1979-09

4.  Indication and contraindications for treatment of thyroid cancer with radioactive iodine.

Authors:  W H BEIERWALTES
Journal:  Ann Intern Med       Date:  1952-07       Impact factor: 25.391

5.  Proceedings: Differentiated thyroid carcinomas. Treatment of distant metastases.

Authors:  J K Harness; N W Thompson; J C Sisson; W H Beierwaltes
Journal:  Arch Surg       Date:  1974-04

6.  Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment.

Authors:  J P Massin; J C Savoie; H Garnier; G Guiraudon; F A Leger; F Bacourt
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

7.  Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.

Authors:  W H Beierwaltes; R H Nishiyama; N W Thompson; J E Copp; A Kubo
Journal:  J Nucl Med       Date:  1982-07       Impact factor: 10.057

8.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

9.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

10.  Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.

Authors:  N A Samaan; P N Schultz; T P Haynie; N G Ordonez
Journal:  J Clin Endocrinol Metab       Date:  1985-02       Impact factor: 5.958

View more
  1 in total

1.  Clinicopathological findings and p53 expression of thyroid cancer in children.

Authors:  T Kobayashi; H Nakanishi; I Yana; I Nishisho; Y Itoh; E Wakasugi; T Takeda; T Mori
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.